Neuroinflammation induced by the peptide amyloid-β (25–35) increase the presence of galectin-3 in astrocytes and microglia and impairs spatial memory

Galectins are animal lectins that bind to β-galactosides, such as lactose and N-acetyllactosamine, contained in glycoproteins or glycolipids. Galectin-1 (Gal-1) and Galectin-3 (Gal-3) are involved in pathologies associated with the inflammatory process, cell proliferation, adhesion, migration, and apoptosis. Recent evidence has shown that the administration of Amyloid-β 25-35 (Aβ25-35) into the hippocampus of rats increases the inflammatory response that is associated with memory impairment and neurodegeneration. Galectins could participate in the modulation of the neuroinflammation induced by the Aβ25-35. The aim of this study was to evaluate the presence of Gal-1 and Gal-3 in the neuroinflammation induced by administration of Aβ25-35 into the hippocampus and to examine spatial memory in the Morris water maze. After the administration of Aβ25-35, animals were tested for learning and spatial memory in the Morris water maze. Behavioral performance showed that Aβ25-35 didn't affect spatial learning but did impair memory, with animals taking longer to find the platform. On the day 32, hippocampus was examined for astrocytes (GFAP), microglia (Iba1), Gal-1 and Gal-3 via immunohistochemical analysis, and the cytokines IL-1β, TNF-α, IFN-γ by ELISA. This study's results showed a significant increase in the expression of Gal-3 in the microglia and astrocytes, while Gal-1 didn't increase in the dorsal hippocampus. The expression of galectins is associated with increased cytokines in the hippocampal formation of Aβ25-35 treated rats. These findings suggest that Gal-3 could participate in the inflammation induced by administration of Aβ25-35 and could be involved in the neurodegeneration progress and memory impairment.

[1]  N. Henderson,et al.  The regulation of inflammation by galectin‐3 , 2009, Immunological reviews.

[2]  T. Lefebvre,et al.  Effect of amyloid-Β (25–35) in hyperglycemic and hyperinsulinemic rats, effects on phosphorylation and O-GlcNAcylation of tau protein , 2017, Neuropeptides.

[3]  R. Dempsey,et al.  Galectin-3 mediates post-ischemic tissue remodeling , 2009, Brain Research.

[4]  Michael T. Heneka,et al.  Innate immune activation in neurodegenerative disease , 2014, Nature Reviews Immunology.

[5]  R. Reiter,et al.  Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-β onto the hippocampus in vivo , 2004, Journal of Neuroimmunology.

[6]  E. Zenteno,et al.  Aβ25-35 injection into the temporal cortex induces chronic inflammation that contributes to neurodegeneration and spatial memory impairment in rats. , 2012, Journal of Alzheimer's disease : JAD.

[7]  J. Pedraza-Chaverri,et al.  S-Allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. , 2004, European journal of pharmacology.

[8]  M. Perretti,et al.  Inhibitory control of endothelial galectin‐1 on in vitro and in vivo lymphocyte trafficking , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Koanhoi Kim,et al.  Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins. , 2003, Biochimica et biophysica acta.

[10]  R. Dwek,et al.  Glycosylation and the immune system. , 2001, Science.

[11]  M. Pasparakis,et al.  Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases , 2009, Nature Reviews Immunology.

[12]  G. Rabinovich,et al.  Galectin-1 Suppresses Autoimmune Retinal Disease by Promoting Concomitant Th2- and T Regulatory-Mediated Anti-Inflammatory Responses1 , 2006, The Journal of Immunology.

[13]  M. Karin,et al.  Genetic dissection of antigen receptor induced-NF-κB activation , 2004 .

[14]  Vishnu Suppiramaniam,et al.  Amyloid beta peptides and glutamatergic synaptic dysregulation , 2008, Experimental Neurology.

[15]  G. Sancesario,et al.  Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track? , 2013, CNS neuroscience & therapeutics.

[16]  D. Hsu,et al.  Role of galectin-3 in prion infections of the CNS. , 2007, Biochemical and biophysical research communications.

[17]  I. D. Limón,et al.  Neurogenesis and morphological-neural alterations closely related to amyloid β-peptide (25–35)-induced memory impairment in male rats , 2017, Neuropeptides.

[18]  John L. Wang,et al.  Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.

[19]  Gabriel A. Rabinovich,et al.  Galectins as modulators of tumour progression , 2005, Nature Reviews Cancer.

[20]  O. Guntinas-Lichius,et al.  Galectin‐3 is upregulated in microglial cells in response to ischemic brain lesions, but not to facial nerve axotomy , 2000, Journal of neuroscience research.

[21]  H. Okano,et al.  Galectin-1 regulates neurogenesis in the subventricular zone and promotes functional recovery after stroke , 2007, Experimental Neurology.

[22]  A. A. Yakovlev,et al.  Amyloid-β (25–35) increases activity of neuronal NO-synthase in rat brain , 2008, Neurochemistry International.

[23]  T. Lawrence The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[24]  A. Nitta,et al.  Production and functions of IL-17 in microglia , 2008, Journal of Neuroimmunology.

[25]  C. Farina,et al.  Astrocytes are active players in cerebral innate immunity. , 2007, Trends in immunology.

[26]  J. Aguilera,et al.  The recombinant C-terminal fragment of tetanus toxin protects against cholinotoxicity by intraseptal injection of β-amyloid peptide (25–35) in rats , 2016, Neuroscience.

[27]  A. Karlsson,et al.  Galectins as inflammatory mediators , 2004, Glycoconjugate Journal.

[28]  D. Butterfield,et al.  Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.

[29]  Fu-Tong Liu,et al.  The immunological potential of galectin-1 and -3. , 2009, Autoimmunity reviews.

[30]  Jürgen Roth,et al.  An introduction to the sugar code , 2017, Histochemistry and Cell Biology.

[31]  K. Blomgren,et al.  Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. , 2015, Cell reports.

[32]  D. Hsu,et al.  Galectin-3 Is a Negative Regulator of Lipopolysaccharide-Mediated Inflammation1 , 2008, The Journal of Immunology.

[33]  R. Morris Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[34]  T. Shimazaki,et al.  A carbohydrate-binding protein, Galectin-1, promotes proliferation of adult neural stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Nakahara,et al.  On the role of galectin-3 in cancer apoptosis , 2005, Apoptosis.

[36]  G. Rabinovich,et al.  Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. , 2012, Immunity.

[37]  J. Priestley,et al.  Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration , 2017, Scientific Reports.

[38]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[39]  T. Issad,et al.  Neuroinflammation induced by amyloid β25–35 modifies mucin-type O-glycosylation in the rat's hippocampus , 2017, Neuropeptides.

[40]  Joseph E LeDoux,et al.  Structural plasticity and memory , 2004, Nature Reviews Neuroscience.

[41]  H. Yoon,et al.  Galectin-3 Exerts Cytokine-Like Regulatory Actions through the JAK–STAT Pathway , 2010, The Journal of Immunology.

[42]  S. Marchal,et al.  Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats , 2013, PloS one.

[43]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.

[44]  Fu-Tong Liu,et al.  Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis1 , 2009, The Journal of Immunology.

[45]  H. Okano,et al.  Galectin-1 is expressed in early-type neural progenitor cells and down-regulates neurogenesis in the adult hippocampus , 2011, Molecular Brain.

[46]  B. Espinosa,et al.  Unilateral injection of Aβ25–35 in the hippocampus reduces the number of dendritic spines in hyperglycemic rats , 2014, Synapse.

[47]  Fred H. Gage,et al.  Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.

[48]  Mark B. Jones,et al.  The regulatory power of glycans and their binding partners in immunity. , 2013, Trends in immunology.

[49]  T. Bates,et al.  β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria , 1999, FEBS letters.

[50]  S. Marchal,et al.  Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats. , 2011, The American journal of pathology.

[51]  L. Baum,et al.  Galectins and Immune Responses-Just How Do They Do Those Things They Do? , 2016, Annual review of immunology.

[52]  Toshihiko Oka,et al.  Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. , 2002, Biochimica et biophysica acta.

[53]  M. Matamales,et al.  Cellular and Molecular Life Sciences REVIEW Modes of Ab toxicity in Alzheimer’s disease , 2022 .

[54]  Daishi Tian,et al.  Galectin‐1 attenuates astrogliosis‐associated injuries and improves recovery of rats following focal cerebral ischemia , 2011, Journal of neurochemistry.

[55]  J. Mordoh,et al.  Galectin-1 receptors in different cell types. , 2005, Journal of biomedical science.

[56]  M. Götz,et al.  Astrocyte reactivity after brain injury—: The role of galectins 1 and 3 , 2015, Glia.

[57]  P. Brundin,et al.  The role of Galectin-3 in α-synuclein-induced microglial activation , 2014, Acta neuropathologica communications.

[58]  A. Karlsson,et al.  Galectin-3 contributes to neonatal hypoxic–ischemic brain injury , 2010, Neurobiology of Disease.

[59]  Riyao Yang,et al.  Galectins in acute and chronic inflammation , 2012, Annals of the New York Academy of Sciences.

[60]  Larry R Squire,et al.  Spatial memory, recognition memory, and the hippocampus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Ávila,et al.  Role of Neuroinflammation in Adult Neurogenesis and Alzheimer Disease: Therapeutic Approaches , 2013, Mediators of inflammation.

[62]  C. Masters,et al.  Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons* , 2015, The Journal of Biological Chemistry.

[63]  Yaniv Ziv,et al.  Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells , 2006, Molecular and Cellular Neuroscience.

[64]  R. Dempsey,et al.  Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling , 2013, Brain Research.

[65]  Y. Kooyk,et al.  Protein-glycan interactions in the control of innate and adaptive immune responses , 2008, Nature Immunology.

[66]  G. Rabinovich,et al.  Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. , 2012, Immunity.

[67]  G. Rabinovich,et al.  Nuclear factor (NF)-κB controls expression of the immunoregulatory glycan-binding protein galectin-1. , 2011, Molecular immunology.

[68]  G. Rabinovich,et al.  A Novel Function for Galectin-1 at the Crossroad of Innate and Adaptive Immunity: Galectin-1 Regulates Monocyte/Macrophage Physiology through a Nonapoptotic ERK-Dependent Pathway1 , 2007, The Journal of Immunology.

[69]  L. Steardo,et al.  Targeting neuroinflammation in Alzheimer’s disease , 2016, Journal of inflammation research.

[70]  D. Butterfield,et al.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.

[71]  A. Privat,et al.  Sigma1 (σ 1) receptor agonists and neurosteroids attenuate β 25–35-amyloid peptide-induced amnesia in mice through a common mechanism , 1998, Neuroscience.

[72]  G. Rabinovich,et al.  Glycobiology of immune responses , 2012, Annals of the New York Academy of Sciences.

[73]  N. Arsenijević,et al.  The roles of Galectin-3 in autoimmunity and tumor progression , 2012, Immunologic research.

[74]  R. Lal,et al.  Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[76]  G. Rabinovich,et al.  Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function , 2011, Cell Death and Differentiation.

[77]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[78]  Hari Shroff,et al.  Single-Molecule Discrimination of Discrete Perisynaptic and Distributed Sites of Actin Filament Assembly within Dendritic Spines , 2010, Neuron.

[79]  J. Hirabayashi,et al.  Galectin-1 induces astrocyte differentiation, which leads to production of brain-derived neurotrophic factor. , 2004, Glycobiology.

[80]  Nguyen Huy Binh,et al.  Galectin-3 expression in delayed neuronal death of hippocampal CA1 following transient forebrain ischemia, and its inhibition by hypothermia , 2011, Brain Research.

[81]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[82]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[83]  G. Rabinovich,et al.  Galectins: structure, function and therapeutic potential , 2008, Expert Reviews in Molecular Medicine.

[84]  Sachiko Sato,et al.  Galectin-3 Is Required for Resident Microglia Activation and Proliferation in Response to Ischemic Injury , 2012, The Journal of Neuroscience.

[85]  Nguyen Huy Binh,et al.  Increase of galectin-3 expression in microglia by hyperthermia in delayed neuronal death of hippocampal CA1 following transient forebrain ischemia , 2011, Neuroscience Letters.

[86]  E. Zenteno,et al.  The role of NOS in the impairment of spatial memory and damaged neurons in rats injected with amyloid beta 25–35 into the temporal cortex , 2011, Pharmacology Biochemistry and Behavior.

[87]  Y. Takenaka,et al.  Galectin-3, a Novel Binding Partner of β-Catenin , 2004, Cancer Research.

[88]  Taekyun Shin,et al.  The pleiotropic effects of galectin-3 in neuroinflammation: a review. , 2013, Acta histochemica.

[89]  Tae-hwan Kim,et al.  Possible involvement of galectin-3 in microglial activation in the hippocampus with trimethyltin treatment , 2012, Neurochemistry International.

[90]  E. Kandel,et al.  The Persistence of Long-Term Memory A Molecular Approach to Self-Sustaining Changes in Learning-Induced Synaptic Growth , 2004, Neuron.

[91]  G. Rabinovich,et al.  When galectins recognize glycans: from biochemistry to physiology and back again. , 2011, Biochemistry.

[92]  E. Wenger,et al.  Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions , 2017, Neuroscience & Biobehavioral Reviews.

[93]  G. Gowing,et al.  Selective Ablation of Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain , 2007, The Journal of Neuroscience.

[94]  Stefano Iacobelli,et al.  Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? , 2002, Trends in immunology.

[95]  F. Pérez-Severiano,et al.  17-AAG improves cognitive process and increases heat shock protein response in a model lesion with Aβ25–35 , 2014, Neuropeptides.

[96]  R. Kiss,et al.  Galectin-1: a small protein with major functions. , 2006, Glycobiology.

[97]  E. Zenteno,et al.  Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats , 2009, Neuroscience Research.

[98]  E. Zenteno,et al.  Alteration of the sialylation pattern and memory deficits by injection of Aβ(25–35) into the hippocampus of rats , 2011, Neuroscience Letters.

[99]  G. Rabinovich,et al.  Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 , 2009, Nature Immunology.